Mingqing Wang

557 total citations
18 papers, 448 citations indexed

About

Mingqing Wang is a scholar working on Molecular Biology, Epidemiology and Nephrology. According to data from OpenAlex, Mingqing Wang has authored 18 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Nephrology. Recurrent topics in Mingqing Wang's work include Autophagy in Disease and Therapy (4 papers), Muscle Physiology and Disorders (3 papers) and Dialysis and Renal Disease Management (3 papers). Mingqing Wang is often cited by papers focused on Autophagy in Disease and Therapy (4 papers), Muscle Physiology and Disorders (3 papers) and Dialysis and Renal Disease Management (3 papers). Mingqing Wang collaborates with scholars based in China and Australia. Mingqing Wang's co-authors include Lu Lu, Wei Xiao, Rong Hu, Lianbo Wei, Jiaxing Zhang, Yang Liu, Tingting Pei, Haiyan You, Fujing Wang and Yanjing Wang and has published in prestigious journals such as Chemical Engineering Journal, European Journal of Pharmacology and BioMed Research International.

In The Last Decade

Mingqing Wang

17 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingqing Wang China 13 191 92 75 62 55 18 448
Giorgia Pierelli Italy 6 156 0.8× 77 0.8× 35 0.5× 59 1.0× 86 1.6× 7 494
Anni Song China 9 142 0.7× 46 0.5× 58 0.8× 48 0.8× 119 2.2× 16 424
Eleni Kokkou Greece 13 176 0.9× 95 1.0× 87 1.2× 115 1.9× 30 0.5× 38 808
Thiago MC Pereira Brazil 8 106 0.6× 79 0.9× 49 0.7× 42 0.7× 30 0.5× 9 406
Kiran Chandrashekar United States 10 136 0.7× 77 0.8× 76 1.0× 30 0.5× 103 1.9× 19 439
Olha Zhenyukh Spain 6 254 1.3× 139 1.5× 68 0.9× 68 1.1× 18 0.3× 7 577
Shih‐Chien Huang Taiwan 13 126 0.7× 77 0.8× 48 0.6× 57 0.9× 21 0.4× 38 433

Countries citing papers authored by Mingqing Wang

Since Specialization
Citations

This map shows the geographic impact of Mingqing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingqing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingqing Wang more than expected).

Fields of papers citing papers by Mingqing Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingqing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingqing Wang. The network helps show where Mingqing Wang may publish in the future.

Co-authorship network of co-authors of Mingqing Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Mingqing Wang. A scholar is included among the top collaborators of Mingqing Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingqing Wang. Mingqing Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Hao, Yuan Zhang, Yang‐Tian Yan, et al.. (2025). P‐Coumaric Acid Improves Skeletal Muscle Atrophy in Chronic Kidney Disease by Modulating TLR4/MyD88/NFκB‐Mediated Inflammation and Oxidative Stress. Journal of Cellular and Molecular Medicine. 29(14). e70659–e70659.
2.
Niu, Wenbo, Zhenjun Chen, Fujing Wang, et al.. (2025). Manganese-based nanozymes as broad-spectrum antioxidants against cisplatin-induced skeletal muscle atrophy. Chemical Engineering Journal. 505. 159213–159213. 1 indexed citations
3.
Yuan, Ningning, Jianxin Diao, Yang‐Tian Yan, et al.. (2024). Targeting ROCK1 in diabetic kidney disease: Unraveling mesangial fibrosis mechanisms and introducing myricetin as a novel antagonist. Biomedicine & Pharmacotherapy. 171. 116208–116208. 4 indexed citations
4.
Yan, Yang‐Tian, Ningning Yuan, Yu‐Chi Chen, et al.. (2024). SKP alleviates the ferroptosis in diabetic kidney disease through suppression of HIF-1α/HO-1 pathway based on network pharmacology analysis and experimental validation. Chinese Medicine. 19(1). 31–31. 12 indexed citations
5.
Zhang, Chi, Tingting Pei, Yang‐Tian Yan, et al.. (2024). Caffeic acid alleviates skeletal muscle atrophy in 5/6 nephrectomy rats through the TLR4/MYD88/NF-kB pathway. Biomedicine & Pharmacotherapy. 174. 116556–116556. 12 indexed citations
6.
Pei, Tingting, Mingqing Wang, Rong Hu, et al.. (2022). Akkermansia Muciniphila Ameliorates Chronic Kidney Disease Interstitial Fibrosis Via the Gut-Renal Axis. SSRN Electronic Journal. 1 indexed citations
7.
Pei, Tingting, Daoqi Zhu, Sixia Yang, et al.. (2022). Bacteroides plebeius improves muscle wasting in chronic kidney disease by modulating the gut‐renal muscle axis. Journal of Cellular and Molecular Medicine. 26(24). 6066–6078. 23 indexed citations
8.
Wang, Fujing, Rong Hu, Jiaxing Zhang, et al.. (2021). High-dose vitamin D3 supplementation ameliorates renal fibrosis by vitamin D receptor activation and inhibiting TGF-β1/Smad3 signaling pathway in 5/6 nephrectomized rats. European Journal of Pharmacology. 907. 174271–174271. 15 indexed citations
9.
Zhang, Jiaxing, Daoqi Zhu, Tingting Pei, et al.. (2021). Chemical profiling of Houttuynia cordata Thunb. by UPLC-Q-TOF-MS and analysis of its antioxidant activity in C2C12 cells. Journal of Pharmaceutical and Biomedical Analysis. 204. 114271–114271. 24 indexed citations
10.
Hu, Rong, Mingqing Wang, Lingyu Liu, et al.. (2020). Calycosin inhibited autophagy and oxidative stress in chronic kidney disease skeletal muscle atrophy by regulating AMPK/SKP2/CARM1 signalling pathway. Journal of Cellular and Molecular Medicine. 24(19). 11084–11099. 43 indexed citations
11.
Wang, Mingqing, Rong Hu, Yanjing Wang, et al.. (2019). Atractylenolide III Attenuates Muscle Wasting in Chronic Kidney Disease via the Oxidative Stress-Mediated PI3K/AKT/mTOR Pathway. Oxidative Medicine and Cellular Longevity. 2019. 1–16. 84 indexed citations
12.
Liu, Yang, Lu Lu, Hua Yue, et al.. (2018). Association of expression of ZNF606 gene from monocytes with the risk of coronary artery disease. Clinical Biochemistry. 60. 44–51. 3 indexed citations
13.
Huang, Yanfeng, Wenbo Niu, Rong Hu, et al.. (2018). FIBP knockdown attenuates growth and enhances chemotherapy in colorectal cancer via regulating GSK3β-related pathways. Oncogenesis. 7(9). 77–77. 24 indexed citations
14.
Wang, Mingqing, Wenbo Niu, Rong Hu, et al.. (2018). POLR1D promotes colorectal cancer progression and predicts poor prognosis of patients. Molecular Carcinogenesis. 58(5). 735–748. 21 indexed citations
15.
Wang, Lingjun, Mingqing Wang, Rong Hu, et al.. (2017). Effect of Zinc Supplementation on Maintenance Hemodialysis Patients: A Systematic Review and Meta-Analysis of 15 Randomized Controlled Trials. BioMed Research International. 2017. 1–11. 48 indexed citations
17.
Gong, Wangqiu, Lu Lu, Jing Chen, et al.. (2016). Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db/db mice via stimulating PPAR-γ, AMPK/Akt/mTOR signaling and autophagy. International Immunopharmacology. 42. 176–184. 60 indexed citations
18.
Liu, Jun-Shan, Lu Lu, Yanfeng Huang, et al.. (2016). Emodin attenuates TNF-α-induced apoptosis and autophagy in mouse C2C12 myoblasts though the phosphorylation of Akt. International Immunopharmacology. 34. 107–113. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026